Valneva reports positive phase-3 results for Chikungunya Vaccine Candidate
Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV). In areas where the virus is circulating it affects one-third to three-quarters of the population. The medical and economic burden is expected to [...]